Clinical Trial Update: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for LY3039478 in combination with dexamethasone in T-ALL/T-LBL (Phase 1/Phase 2) completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• LY3039478

Snippet

Sponsor: Eli Lilly and Company | Conditions: T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoblastic Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-06